Intervention

Modafinil

ClinicalTrials.gov intervention label

Clinical trials18

Recruiting2

Common conditions25

Lead sponsors shown15

Clinical trials

18 shown

Cognitive Strategies in Early Psychosis 2NCT07263022 · 2026-07-17

Cognitive Strategies in Early Psychosis 1NCT07231497 · 2025-10-31

Study Effects of Preoperative Modafinil on Recovery Profile of Morbidly Obese Patients Scheduled for Bariatric Surgery if it Can Enhance Recovery From AnesthesiaNCT07128719 · 2024-01-01

Treatment for Cognitive Impairment in DepressionNCT04317001 · 2018-12-01

Cognitive Behavioral Therapy, Modafinil, or Both for Multiple Sclerosis FatigueNCT03621761 · 2018-11-15

Modafinil's Effects on Cognition in Remitted MDDNCT03620253 · 2018-10-15

Touchscreen-based Cognitive Tests in Healthy VolunteersNCT03469089 · 2018-03-12

Treatment of Fatigue With Methylphenidate, Modafinil and Amantadine in Multiple SclerosisNCT03185065 · 2017-10-04

A Multidisciplinary Approach to Manage Gait Difficulty in Parkinson PatientsNCT02857244 · 2016-11-01

Antipsychotic Effects on Brain Function in SchizophreniaNCT01913327 · 2013-04-01

Study With Modafinil in Patients Treated With Docetaxel-Based Chemotherapy for Metastatic Breast or Prostate Cancer (MOTIF)NCT00917748 · 2009-06-01

Modafinil for the Treatment of Fatigue in Lung Cancer V9.0NCT00829322 · 2009-02-01

Modafinil Treatment for Cocaine Dependence and HIV High-Risk BehaviorNCT00368290 · 2006-09-01

Treatment of Apathy in Alzheimer's Disease With ModafinilNCT01172145 · 2005-07-01

Effectiveness of Modafinil for Treating Fatigue in Adults With HIV/AIDSNCT00118378 · 2004-12-01

Modafinil in Multiple SclerosisNCT00142402 · 2003-06-01

Effects of Modafinil on Brain Function in Patients With SchizophreniaNCT00057707 · 2003-03-26

Modafinil Augmentation Therapy for Excessive Daytime Sleepiness and Negative Symptoms in Patients With SchizophreniaNCT00546403 · 2003-02-01

Common conditions

Leading sponsors

University of Minnesota2 Ain Shams University1 Brown University1 Johns Hopkins University1 Kessler Foundation1 Kyle Kampman1 National Institute of Mental Health (NIMH)1 New York State Psychiatric Institute1 Sanofi1 Stanford University1 Unity Health Toronto1 University of California, San Francisco1 University of Chicago1 University of Eastern Finland1 University of Michigan1

Trial status mix

COMPLETED11

RECRUITING2

TERMINATED2

WITHDRAWN2

UNKNOWN1

Phase mix

PHASE37

PHASE44

NA3

PHASE12

PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.